A network model of genomic hormone interactions underlying dementia and its translational validation through

Erfan Younesi1, Martin Hofmann-Apitius

  • 1Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing-SCAI, Schloss Birlinghoven, Sankt Augustin 53754, Germany. erfan.younesi@scai.fraunhofer.de

Abstract

Insights

This study reveals a network of seven hormone signaling pathways linked to dementia risk. The findings offer a new platform for developing dementia therapies and diagnostics.

Area of Science:

  • Endocrinology
  • Neuroscience
  • Systems Biology

Background:

  • Dementia risk is linked to hormones beyond sex hormones, but mechanisms are unclear.
  • Existing research lacks an integrated view of hormone signaling in dementia.
  • The potential for hormone-based dementia therapeutics and diagnostics is undervalued.

Purpose of the Study:

  • To construct an integrated hormone interaction network for dementia.
  • To identify key hormone signaling pathways involved in dementia risk.
  • To explore translational applications for dementia diagnosis and treatment.

Main Methods:

  • An integrative, data-driven approach was used to build a global hormone interaction network.
  • The network was refined to a model of convergent hormone signaling pathways.
  • Biological, clinical, and translational relevance was assessed using multiple validation methods.

Main Results:

  • A well-connected hormone interaction network underlying dementia was identified.
  • Seven key hormone signaling pathways, including estrogen and insulin, converge in this network.
  • Validation confirmed that these pathways significantly contribute to dementia pathogenesis.

Conclusions:

  • The developed integrated network model provides a translational platform for dementia research.
  • This model can aid in identifying novel therapeutic targets for dementia.
  • Candidate biomarkers for dementia-spectrum disorders can be discovered using this framework.